GO
Loading...

What's ahead for medical science with Mallinckrodt CEO

Monday, 25 Aug 2014 | 6:45 PM ET

Mark Trudeau, Mallinckrodt Pharmaceuticals president and CEO, discusses the company's focus on strategy and acquisitions, with Mad Money host Jim Cramer.